UltraBio Technologies, Inc is a University of Washington spinoff company from the Department of Laboratory Medicine. The company is built off of over 20 years of laboratory and clinical experience with infectious diseases.

At UltraBio, we are developing best in class qPCR assay kits for HIV-1 DNA, with the goal of allowing researchers to generate crucial insights towards finding a permanent cure for HIV.